Zura Bio Limited (ZURA)
NASDAQ: ZURA
· Real-Time Price · USD
3.93
-0.17 (-4.15%)
At close: Oct 03, 2025, 3:59 PM
4.12
4.83%
After-hours: Oct 03, 2025, 07:53 PM EDT
-4.15% (1D)
| Bid | 3.85 |
| Market Cap | 255.52M |
| Revenue (ttm) | 2K |
| Net Income (ttm) | -67.76M |
| EPS (ttm) | -0.69 |
| PE Ratio (ttm) | -5.7 |
| Forward PE | -5.26 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.08 |
| Volume | 962,455 |
| Avg. Volume (20D) | 1,647,026 |
| Open | 4.00 |
| Previous Close | 4.10 |
| Day's Range | 3.86 - 4.20 |
| 52-Week Range | 0.97 - 5.07 |
| Beta | 0.25 |
| Ex-Dividend Date | n/a |
About ZURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-10.07%
Zura Bio shares are trading lower after the compan...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway anti...